Medicure (MCUJF) Interest & Investment Income (2009 - 2026)
Medicure (MCUJF) posted quarterly Interest & Investment Income of $11667.3 for Q1 2026, up 149.24% year-over-year from $4681.2 in Q1 2025, and up 702.83% quarter-over-quarter from $1453.3 in Q3 2025.
Medicure (MCUJF) Interest & Investment Income (2009 - 2026) Analysis & Trends
Medicure's Interest & Investment Income history runs 11 years deep, the most recent figure standing at $11667.3 for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 149.24% year-over-year to $11667.3; the TTM figure through Mar 2026 stood at -$23769.6 (down 108.98% YoY), while the FY2009 annual figure was -$222642.2, changed N/A from the prior year.
- Interest & Investment Income for Q1 2026 stood at $11667.3, up from $1453.3 in the prior quarter.
- The five-year high for Interest & Investment Income was $1.2 million in Q3 2022, with the low at -$37847.8 in Q1 2024.
- The 5-year median for Interest & Investment Income is $1453.3 (2025), against an average of $213515.3.
- The sharpest annual moves came in 2024 and 2026: Interest & Investment Income tumbled 103.89% in 2024, then soared 149.24% in 2026.
- Medicure's Interest & Investment Income stood at $1.2 million in 2022, then plunged by 72.11% to $339398.4 in 2023, then sank by 103.89% to -$13195.0 in 2024, then surged by 111.01% to $1453.3 in 2025, then surged by 702.83% to $11667.3 in 2026.
- Business Quant data shows MCUJF's Interest & Investment Income at $11667.3 in Q1 2026, $1453.3 in Q3 2025, and -$23695.2 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 154.39 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 31.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 12.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Medicure | 97.06 Mn | 95.93 Mn | 2.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11,667.29 |
| Sep 30, 2025 | 1,453.27 |
| Mar 31, 2025 | -23,695.16 |
| Sep 30, 2024 | -13,194.96 |
| Mar 31, 2024 | -37,847.77 |
| Sep 30, 2023 | 339,398.36 |
| Sep 30, 2022 | 1.22 Mn |
| Mar 31, 2021 | 95,601.99 |
| Mar 31, 2020 | 54,450.30 |
| Mar 31, 2019 | -142,868.47 |
| Feb 28, 2011 | -146.29 |
| Nov 30, 2010 | 323.65 |
| Feb 28, 2010 | 15.22 |
| Nov 30, 2009 | 3,953.97 |
| Aug 31, 2009 | -1,438.65 |
| May 31, 2009 | -415,978.90 |
| Feb 28, 2009 | 23,258.74 |